Metraipolis › archive › dc_202bcf0be5ba

Characterizing and quantifying disease impacts of generalized myasthenia gravis (gMG) in the United States: insights from patient and caregiver interviews and… — Europe PMC PMID:42337141

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42337141
DOI
10.1186/s41687-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-19T05:39:38.104Z
SHA-256 of the archived text
27ae80852e0ff524322c46eaeff5ca9474bc8149b8b5a0a57d8648ef475f6e85
Stable URL of this page
https://metraipolis.com/documento/dc_202bcf0be5ba

How to cite

Characterizing and quantifying disease impacts of generalized myasthenia gravis (gMG) in the United States: insights from patient and caregiver interviews and… — Europe PMC PMID:42337141 — Europe PMC (en), https://europepmc.org/article/MED/42337141 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_202bcf0be5ba (Metraipolis archive dc_202bcf0be5ba, sha256 27ae80852e0ff524322c46eaeff5ca9474bc8149b8b5a0a57d8648ef475f6e85)
BibTeX
@misc{dc202bcf0be5ba,
  title = {Characterizing and quantifying disease impacts of generalized myasthenia gravis (gMG) in the United States: insights from patient and caregiver interviews and… — Europe PMC PMID:42337141},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42337141},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_202bcf0be5ba; sha256 27ae80852e0ff524322c46eaeff5ca9474bc8149b8b5a0a57d8648ef475f6e85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42337141. Agents can read the archived copy with the MCP tool read_document.